These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
302 related items for PubMed ID: 2846876
21. Transcriptional interaction between retroviral long terminal repeats (LTRs): mechanism of 5' LTR suppression and 3' LTR promoter activation of c-myc in avian B-cell lymphomas. Boerkoel CF, Kung HJ. J Virol; 1992 Aug; 66(8):4814-23. PubMed ID: 1321271 [Abstract] [Full Text] [Related]
22. Site-specific rearrangements in the long terminal repeat of extra mouse mammary tumor proviruses in murine T-cell leukemias. Michalides R, Wagenaar E. Virology; 1986 Oct 15; 154(1):76-84. PubMed ID: 3019010 [Abstract] [Full Text] [Related]
31. Sequence and genetic analyses of the 3' terminus and integration sites of the RIII/Sa mouse mammary tumor (MMTV) exogenous provirus. Popken-Harris P, Pliml L, Harris L. Virus Genes; 2001 Oct 15; 23(1):35-43. PubMed ID: 11556399 [Abstract] [Full Text] [Related]
32. Linkage of superantigen-like stimulation of syngeneic T cells in a mouse model of follicular center B cell lymphoma to transcription of endogenous mammary tumor virus. Tsiagbe VK, Yoshimoto T, Asakawa J, Cho SY, Meruelo D, Thorbecke GJ. EMBO J; 1993 Jun 15; 12(6):2313-20. PubMed ID: 8389694 [Abstract] [Full Text] [Related]
33. Mutational and functional analysis of the C-terminal region of the C3H mouse mammary tumor virus superantigen. Wrona TJ, Lozano M, Binhazim AA, Dudley JP. J Virol; 1998 Jun 15; 72(6):4746-55. PubMed ID: 9573239 [Abstract] [Full Text] [Related]
34. Conversion of mouse mammary tumor virus to a lymphomagenic virus. Bhadra S, Lozano MM, Dudley JP. J Virol; 2005 Oct 15; 79(19):12592-6. PubMed ID: 16160187 [Abstract] [Full Text] [Related]
35. A small region of the mouse mammary tumor virus long terminal repeat confers glucocorticoid hormone regulation on a linked heterologous gene. Majors J, Varmus HE. Proc Natl Acad Sci U S A; 1983 Oct 15; 80(19):5866-70. PubMed ID: 6310597 [Abstract] [Full Text] [Related]
36. Construction of a clonable, infectious, and tumorigenic mouse mammary tumor virus provirus and a derivative genetic vector. Shackleford GM, Varmus HE. Proc Natl Acad Sci U S A; 1988 Dec 15; 85(24):9655-9. PubMed ID: 2849114 [Abstract] [Full Text] [Related]
37. Activation of the mouse mdr3 gene by insertion of retroviruses in multidrug-resistant P388 tumor cells. Lepage P, Devault A, Gros P. Mol Cell Biol; 1993 Dec 15; 13(12):7380-92. PubMed ID: 8246958 [Abstract] [Full Text] [Related]
38. T cell receptor V beta repertoire in mice lacking endogenous mouse mammary tumor provirus. Braun MY, Jouvin-Marche E, Marche PN, MacDonald HR, Acha-Orbea H. Eur J Immunol; 1995 Mar 15; 25(3):857-62. PubMed ID: 7705418 [Abstract] [Full Text] [Related]
39. Addition of substitution of simian virus 40 enhancer sequences into the Moloney murine leukemia virus (M-MuLV) long terminal repeat yields infectious M-MuLV with altered biological properties. Hanecak R, Pattengale PK, Fan H. J Virol; 1988 Jul 15; 62(7):2427-36. PubMed ID: 2836623 [Abstract] [Full Text] [Related]
40. naf, a trans-regulating negative-acting factor encoded within the mouse mammary tumor virus open reading frame region. Salmons B, Erfle V, Brem G, Günzburg WH. J Virol; 1990 Dec 15; 64(12):6355-9. PubMed ID: 2173798 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]